AI in Ophthalmology Market to Reach $1.36 Billion by 2030

The AI in Ophthalmology market is projected to grow significantly, reaching $1.36 billion by 2030, up from $209.23 million in 2024, announced in a press release. This growth is driven by advancements in imaging technology, the expansion of teleophthalmology services, and the increasing prevalence of eye diseases.

AI technologies are being increasingly adopted in ophthalmology due to their ability to rapidly analyze complex retinal images, facilitating early detection and treatment of conditions such as diabetic retinopathy and glaucoma. The integration of advanced imaging techniques like Optical Coherence Tomography (OCT) with AI has enhanced diagnostic precision, providing detailed views of ocular structures.

The rise of teleophthalmology, particularly in underserved regions, is also contributing to market growth. AI enables automated analysis of retinal images, supporting remote diagnosis and reducing the need for in-person consultations. This approach not only increases access to eye care but also optimizes resource utilization in healthcare systems.

Moreover, AI's capability to analyze data from Electronic Health Records (EHRs) aids in creating personalized treatment plans, predicting disease progression, and recommending tailored interventions. These advancements are expected to further fuel the growth of the AI in Ophthalmology market.